CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

Abdel Kareem Azab, Judith M. Runnels, Costas Pitsillides, Anne Sophie Moreau, Feda Azab, Xavier Leleu, Xiaoying Jia, Renee Wright, Beatriz Ospina, Alicia L. Carlson, Clemens Alt, Nicholas Burwick, Aldo M. Roccaro, Hai T. Ngo, Mena Farag, Molly R. Melhem, Antonio Sacco, Nikhil C. Munshi, Teru Hideshima, Barrett J. RollinsKenneth C. Anderson, Andrew L. Kung, Charles P. Lin, Irene M. Ghobrial

Research output: Contribution to journalArticlepeer-review

346 Scopus citations

Fingerprint

Dive into the research topics of 'CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences